![]()
Phenotype Annotations Click to see Annotation Detail View
Mammalian Phenotype Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | abnormal adipose tissue amount | | IAGP | | 619672 | | RGD | | abnormal adipose tissue amount | | IAGP | | 21406435 | compared to LETO rats | RGD | | abnormal body temperature homeostasis | | IAGP | | 1625204 | LETO | RGD | | abnormal circadian temperature homeostasis | | IAGP | | 1625204 | LETO | RGD | | abnormal circulating alanine transaminase level | | IAGP | | 21406435 | compared to LETO rats and OLETF rats treated with rosiglitazone | RGD | | abnormal taste sensitivity | | IAGP | | 1625203 | LETO | RGD | | decreased adiponectin level | | IAGP | | 21406435 | compared to LETO rats and OLETF rats treated with rosiglitazone | RGD | | decreased body weight | | IAGP | | 625760 | compared to F344/Slc | RGD | | decreased circulating adiponectin level | | IAGP | | 21406435 | compared to LETO rats and OLETF rats treated with rosiglitazone | RGD | | hyperglycemia | | IAGP | | 1625203 | LETO | RGD | | impaired glucose tolerance | | IAGP | | 21406435 | compared to LETO rats and OLETF rats treated with rosiglitazone | RGD | | increased body weight | | IAGP | | 61072 | | RGD | | increased body weight | | IAGP | | 21406435 | compared to LETO rats | RGD | | increased circulating free fatty acids level | | IAGP | | 21406435 | compared to LETO rats and OLETF rats treated with rosiglitazone | RGD | | increased circulating glucose level | | IAGP | | 21406435 | compared to LETO rats | RGD | | increased circulating insulin level | | IAGP | | 1625203 | LETO | RGD | | increased circulating insulin level | | IAGP | | 21406435 | compared to LETO rats and OLETF rats treated with rosiglitazone | RGD | | increased circulating leptin level | | IAGP | | 1625203 | LETO | RGD | | increased circulating triglyceride level | | IAGP | | 21406435 | compared to LETO rats and OLETF rats treated with rosiglitazone | RGD | | increased fasting circulating glucose level | | IAGP | | 61072 | | RGD | | increased food intake | | IAGP | | 1625200 | LETO | RGD | | increased food intake | | IAGP | | 21406435 | compared to LETO rats | RGD | | insulin resistance | | IAGP | | 21406435 | compared to LETO rats and OLETF rats treated with rosiglitazone | RGD | | |